![PDF) Efficacy, Safety and Cost-effectiveness Comparison of Rosuvastatin 5mg with Atorvastatin 20mg in Hypercholesterolaemic Patients: A Prospective Open Label Clinical Study PDF) Efficacy, Safety and Cost-effectiveness Comparison of Rosuvastatin 5mg with Atorvastatin 20mg in Hypercholesterolaemic Patients: A Prospective Open Label Clinical Study](https://i1.rgstatic.net/publication/332342882_Efficacy_Safety_and_Cost-effectiveness_Comparison_of_Rosuvastatin_5mg_with_Atorvastatin_20mg_in_Hypercholesterolaemic_Patients_A_Prospective_Open_Label_Clinical_Study/links/5caeca07299bf120975d7568/largepreview.png)
PDF) Efficacy, Safety and Cost-effectiveness Comparison of Rosuvastatin 5mg with Atorvastatin 20mg in Hypercholesterolaemic Patients: A Prospective Open Label Clinical Study
![Prediction of Clinical Irrelevance of PK Differences in Atorvastatin Using PK/PD Models Derived From Literature‐Based Meta‐Analyses - Vargo - 2014 - Clinical Pharmacology & Therapeutics - Wiley Online Library Prediction of Clinical Irrelevance of PK Differences in Atorvastatin Using PK/PD Models Derived From Literature‐Based Meta‐Analyses - Vargo - 2014 - Clinical Pharmacology & Therapeutics - Wiley Online Library](https://ascpt.onlinelibrary.wiley.com/cms/asset/d03130a8-219f-42ea-872e-802d48a1cb1d/cptclpt201466-gra-0001-m.jpg)
Prediction of Clinical Irrelevance of PK Differences in Atorvastatin Using PK/PD Models Derived From Literature‐Based Meta‐Analyses - Vargo - 2014 - Clinical Pharmacology & Therapeutics - Wiley Online Library
![PDF] An updated review of interactions of statins with antibacterial and antifungal agents | Semantic Scholar PDF] An updated review of interactions of statins with antibacterial and antifungal agents | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/8b3ac19bea02f50f9db84cd93676fc2eaf1c2e0e/2-Table1-1.png)